← All stocks

JNJ vs MRK

Johnson & Johnson Common Stock vs Merck & Company Inc. Common Stock (new). Side-by-side ACCE scores, valuation, profitability, and growth.

JNJ
Johnson & Johnson Common Stock
Healthcare
269.47
650.65B
MRK
Merck & Company Inc. Common Stock (new)
Healthcare
149.50
362.35B
ACCE scores
JNJ
MRK
Composite score
Out of 100
66
54
Growth
28
28
Value
48
39
Quality
96
50
Momentum
90
97
Valuation
JNJ
MRK
Price
269.47
149.50
Market cap
650.65B
362.35B
Trailing P/E
31.36
117.50
Forward P/E
21.10
15.15
EV / EBITDA
19.99
28.40
Dividend yield
1.9%
2.3%
Profitability
JNJ
MRK
ROE
25.7%
7.0%
Net margin
21.5%
4.8%
Debt / equity
0.59
0.94
Free cash flow
19.70B
12.36B
Growth
JNJ
MRK
Revenue growth (YoY)
6.6%
5.1%
Earnings growth (YoY)
-0.9%
-19.3%
Analyst target
277.91
152.96
See full analysis